[1] |
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71(3):209-249. doi: 10.3322/caac.21660.
|
[2] |
Clarke MA, Long BJ, Del Mar Morillo A, et al. Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis[J]. JAMA Intern Med, 2018, 178(9):1210-1222. doi: 10.1001/jamainternmed.2018.2820.
pmid: 30083701
|
[3] |
Crosbie EJ, Kitson SJ, McAlpine JN, et al. Endometrial cancer[J]. Lancet, 2022, 399(10333):1412-1428. doi: 10.1016/S0140-6736(22)00323-3.
pmid: 35397864
|
[4] |
ACOG Committee Opinion No. 734: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding[J]. Obstet Gynecol, 2018, 131(5):e124-e129. doi: 10.1097/AOG.0000000000002631.
|
[5] |
Ai F, Wang Y, Zhou L, et al. Clinicopathologic characteristics and risk factors for endometrial malignancy in postmenopausal women with endometrial thickening[J]. Menopause, 2022, 29(2):137-143. doi: 10.1097/GME.0000000000001903.
pmid: 35013057
|
[6] |
Du J, Li Y, Lv S, et al. Endometrial sampling devices for early diagnosis of endometrial lesions[J]. J Cancer Res Clin Oncol, 2016, 142(12):2515-2522. doi: 10.1007/s00432-016-2215-3.
pmid: 27515060
|
[7] |
Costas L, Palomero L, Benavente Y, et al. Defining a mutational signature for endometrial cancer screening and early detection[J]. Cancer Epidemiol, 2019, 61:129-132. doi: 10.1016/j.canep.2019.06.003.
pmid: 31238232
|
[8] |
Yen TT, Miyamoto T, Asaka S, et al. Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma[J]. Gynecol Oncol, 2018, 150(3):426-431. doi: 10.1016/j.ygyno.2018.06.025.
|
[9] |
Bafligil C, Thompson DJ, Lophatananon A, et al. Association between genetic polymorphisms and endometrial cancer risk: a systematic review[J]. J Med Genet, 2020, 57(9):591-600. doi: 10.1136/jmedgenet-2019-106529.
pmid: 32066633
|
[10] |
Wang Y, Li L, Douville C, et al. Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers[J]. Sci Transl Med, 2018, 10(433):eaap8793. doi: 10.1126/scitranslmed.aap8793.
|
[11] |
Akahane T, Kitazono I, Yanazume S, et al. Next-generation sequencing analysis of endometrial screening liquid-based cytology specimens: a comparative study to tissue specimens[J]. BMC Med Genomics, 2020, 13(1):101. doi: 10.1186/s12920-020-00753-6.
pmid: 32652986
|
[12] |
Vizza E, Corrado G, De Angeli M, et al. Correction to: Serum DNA integrity index as a potential molecular biomarker in endometrial cancer[J]. J Exp Clin Cancer Res, 2018, 37(1):35. doi: 10.1186/s13046-018-0708-4.
pmid: 29463277
|
[13] |
Shen S, Guo J, Lv N, et al. RNA m6A methylation regulators in endometrial cancer (Review)[J]. Int J Oncol, 2022, 61(6):155. doi: 10.3892/ijo.2022.5445.
|
[14] |
Liew PL, Huang RL, Wu TI, et al. Combined genetic mutations and DNA-methylated genes as biomarkers for endometrial cancer detection from cervical scrapings[J]. Clin Epigenetics, 2019, 11(1):170. doi: 10.1186/s13148-019-0765-3.
|
[15] |
Herzog C, Marín F, Jones A, et al. A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control Sets[J]. J Clin Oncol, 2022, 40(33):3828-3838. doi: 10.1200/JCO.22.00266.
|
[16] |
Sangtani A, Wang C, Weaver A, et al. Combining copy number, methylation markers, and mutations as a panel for endometrial cancer detection via intravaginal tampon collection[J]. Gynecol Oncol, 2020, 156(2):387-392. doi: 10.1016/j.ygyno.2019.11.028.
pmid: 31787246
|
[17] |
van den Helder R, Wever B, van Trommel NE, et al. Non-invasive detection of endometrial cancer by DNA methylation analysis in urine[J]. Clin Epigenetics, 2020, 12(1):165. doi: 10.1186/s13148-020-00958-7.
pmid: 33143739
|
[18] |
Dossus L, Kouloura E, Biessy C, et al. Prospective analysis of circulating metabolites and endometrial cancer risk[J]. Gynecol Oncol, 2021, 162(2):475-481. doi: 10.1016/j.ygyno.2021.06.001.
pmid: 34099314
|
[19] |
Troisi J, Mollo A, Lombardi M, et al. The Metabolomic Approach for the Screening of Endometrial Cancer: Validation from a Large Cohort of Women Scheduled for Gynecological Surgery[J]. Biomolecules, 2022, 12(9):1229. doi: 10.3390/biom12091229.
|
[20] |
Han Y, Park IS, Kim SI, et al. Increasing serum gamma-glutamyltransferase level accompanies a rapid increase in the incidence of endometrial cancer in Korea: A nationwide cohort study[J]. Gynecol Oncol, 2021, 161(3):864-870. doi: 10.1016/j.ygyno.2021.03.024.
pmid: 33795129
|
[21] |
Troisi J, Raffone A, Travaglino A, et al. Development and Validation of a Serum Metabolomic Signature for Endometrial Cancer Screening in Postmenopausal Women[J]. JAMA Netw Open, 2020, 3(9):e2018327. doi: 10.1001/jamanetworkopen.2020.18327.
|
[22] |
Trabert B, Eldridge RC, Pfeiffer RM, et al. Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial[J]. Int J Cancer, 2017, 140(3):600-610. doi: 10.1002/ijc.30478.
pmid: 27770434
|
[23] |
Qin R, Liao M, Qin W, et al. The diagnostic value of serum YKL-40 in endometrial cancer: a meta-analysis[J]. Biomarkers, 2022, 27(3):215-221. doi: 10.1080/1354750X.2021.2024603.
|
[24] |
Zhang Q, Yu X, Lin M, et al. Multi-b-value diffusion weighted imaging for preoperative evaluation of risk stratification in early-stage endometrial cancer[J]. Eur J Radiol, 2019, 119:108637. doi: 10.1016/j.ejrad.2019.08.006.
|
[25] |
Ma X, Ren X, Ma F, et al. Volumetric apparent diffusion coefficient (ADC) histogram metrics as imaging biomarkers for pretreatment predicting response to fertility-sparing treatment in patients with endometrial cancer[J]. Gynecol Oncol, 2022, 165(3):594-602. doi: 10.1016/j.ygyno.2022.04.008.
|
[26] |
Paraskevaidi M, Morais C, Ashton KM, et al. Detecting Endometrial Cancer by Blood Spectroscopy: A Diagnostic Cross-Sectional Study[J]. Cancers(Basel), 2020, 12(5):1256. doi: 10.3390/cancers12051256.
|
[27] |
Takahashi Y, Sone K, Noda K, et al. Automated system for diagnosing endometrial cancer by adopting deep-learning technology in hysteroscopy[J]. PLoS One, 2021, 16(3):e0248526. doi: 10.1371/journal.pone.0248526.
|
[28] |
Lu KH, Broaddus RR. Endometrial Cancer[J]. N Engl J Med, 2020, 383(21):2053-2064. doi: 10.1056/NEJMra1514010.
|
[29] |
Lim N, Hickey M, Young GP, et al. Screening and risk reducing surgery for endometrial or ovarian cancers in Lynch syndrome: a systematic review[J]. Int J Gynecol Cancer, 2022, 32(5):646-655. doi: 10.1136/ijgc-2021-003132.
pmid: 35437274
|
[30] |
Warring SK, Borah B, Moriarty J, et al. The cost of diagnosing endometrial cancer: Quantifying the healthcare cost of an abnormal uterine bleeding workup[J]. Gynecol Oncol, 2022, 164(1):93-97. doi: 10.1016/j.ygyno.2021.10.079.
|